Skip to main content
Equibles
UHS logo

UHS · Universal Health Services Inc

Track UHS — free

Use UHS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$169.65 +0.44 (+0.26%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.00B
Shares
58.94M

UHS metrics

93 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$169.65
Market cap
$10.00B

Price action

19 metrics
Price change (1W)
-1.2%
Price change (30D)
-1.8%
Price change (3M)
+16.9%
Price change (6M)
-11.9%
Price change (YTD)
-22.2%
Price change (1Y)
-8.6%
Trailing year
Price change (5Y)
+8.6%
52-week high
$244.18
52-week low
$141.17
Change from 52-week high
-30.5%
Change from 52-week low
+20.2%
Annualized volatility
32.1%
Beta
0.2
RSI (14D)
50.7
Price vs SMA 50
+3.9%
Price vs SMA 200
-8.8%
Avg volume (3M)
865,251
Relative volume
0.5
Average dollar volume
$136.37M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
58.94M

Valuation

12 metrics
P / E (TTM)
6.9
Trailing earnings · reciprocal yield 14.4%
PEG ratio
0.7
EV / revenue
0.8×
reciprocal yield 123.1%
EV / EBITDA
5.4×
reciprocal yield 18.4%
EV / EBIT
7.1×
reciprocal yield 14.0%
P / sales
0.6×
reciprocal yield 181.2%
P / book
1.3
reciprocal yield 75.1%
FCF yield
8.5%
TTM · current market cap
Buyback yield
10.7%
P / FCF
11.8
reciprocal yield 8.5%
P / operating cash flow
5.6
reciprocal yield 18.0%
Earnings yield
15.3%

Historical valuation

8 metrics
P / E historical average (3Y)
11.8×
reciprocal yield 8.5%
P / E historical average (5Y)
12.0×
reciprocal yield 8.3%
EV / revenue historical average (3Y)
1.0×
reciprocal yield 96.4%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 95.6%
EV / EBIT historical average (3Y)
10.6×
reciprocal yield 9.5%
EV / EBIT historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / EBITDA historical average (3Y)
7.6×
reciprocal yield 13.2%
EV / EBITDA historical average (5Y)
7.7×
reciprocal yield 12.9%

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
3.2%
Shareholder yield
11.2%
Dividend / share (TTM)
$0.80
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-09-01

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
—
Operating margin
11.4%
Trailing 12 months
Net margin
8.4%
Gross profit (TTM)
—
Operating profit (TTM)
$2.06B
Net income (TTM)
$1.53B
Trailing 12 months
Diluted EPS (TTM)
$24.50
FCF margin
4.7%
Effective tax rate
23.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+8.3%
Year over year
Net income growth YoY
+1.5%
Revenue (TTM)
$18.11B
Trailing 12 months
EPS growth YoY
+10.1%
Shares change YoY
-7.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.0%
Revenue CAGR (5Y)
+8.5%
EPS CAGR (3Y)
+36.2%
EPS CAGR (5Y)
+16.0%
FCF CAGR (3Y)
+48.0%
FCF CAGR (5Y)
-12.2%

Quality

14 metrics
Return on equity
20.3%
Return on assets
9.6%
Debt / equity
0.6
Current ratio
1.1
EBITDA (TTM)
$2.70B
Free cash flow (TTM)
$845.40M
Quick ratio
1.1
Interest coverage
13.1
Net debt / EBITDA
1.7
Return on invested capital
12.9%
Trailing 12 months
Net cash
−$4.71B
Latest balance sheet
Cash & equivalents
$138.80M
Total assets
$15.94B
Total debt
$4.85B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.80B
Capital expenditures (TTM)
$954.90M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$95.39M
R&D / revenue
—
Stock compensation / revenue
0.5%

Ownership (13F)

3 metrics
13F filers
598
13F filer change QoQ
-59
Institutional ownership
89.4%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 352915 CUSIP 913903100 13F (30d) 326 filings 322 filers Visit website Investor relations